Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC (Q57069952)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 September 2018
edit
Language Label Description Also known as
English
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
scientific article published on 25 September 2018

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit